Physician profile
Gregory J Rau
NPI 1528006038
$211,289.35
in general payments reported to CMS, 2019-2025
26 companies · $58K in 2025
The $58K reported for 2025 was more than what 99% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15K · 2022: $20K · 2023: $64K · 2024: $55K · 2025: $58K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $139K · Travel and Lodging: $15K · Food and Beverage: $13K · Consulting Fee: $9,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $138,616.72 |
| Travel and Lodging | $14,888.78 |
| Food and Beverage | $13,168.68 |
| Consulting Fee | $9,369.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $59,824.40 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Abbvie INC. | $58,569.20 | 2021-2025 | |
| Amgen INC. | $37,516.37 | 2022-2025 | Otezla, Otezla |
| Leo Pharma INC. | $28,037.41 | 2021-2025 | Adbry, Anzupgo |
| Pfizer INC. | $15,354.12 | 2021-2025 | |
| Galderma Laboratories, L.P. | $5,609.72 | 2023-2025 | Nemluvio, Aklief |
| E.R. Squibb & Sons, L.L.C. | $699.66 | 2022-2025 | Sotyktu |
| Journey Medical Corporation | $590.90 | 2025 | |
| Janssen Biotech, INC. | $577.77 | 2022-2025 | Tremfya |
| Genzyme Corporation | $562.67 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $466.05 | 2021-2025 | Ilumya, Absorica Ld, Winlevi |
| Regeneron Healthcare Solutions, INC. | $457.20 | 2021-2025 | Dupixent, Libtayo |
| Ucb, INC. | $456.45 | 2022-2025 | Bimzelx, Cimzia |
| Incyte Corporation | $408.51 | 2021-2025 | Opzelura |
| Dermavant Sciences, INC. | $384.69 | 2023-2024 | Vtama |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $366.60 | 2021-2025 | |
| Almirall LLC | $363.37 | 2022-2025 | Seysara, Klisyri |
| Arcutis Biotherapeutics, INC. | $253.54 | 2023-2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $189.84 | 2021-2025 | Cabtreo, Jublia, Duobrii |
| Organon LLC | $182.77 | 2025 | Vtama, Nexplanon |
| Mayne Pharma Commercial LLC | $120.25 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.42 | 2023-2025 | Spevigo, Cyltezo |
| Epi Health, LLC | $83.07 | 2021-2022 | |
| Verrica Pharmaceuticals INC. | $43.03 | 2024 | Ycanth |
| Botanix Sb INC | $37.67 | 2025 | Sofdra |
| Vyne Pharmaceuticals INC. | $15.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Rau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.